PCM

Penserra Capital Management Portfolio holdings

AUM $7.17B
1-Year Return 49.58%
This Quarter Return
+4.69%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$73.4M
Cap. Flow %
-1.57%
Top 10 Hldgs %
14.09%
Holding
1,668
New
221
Increased
658
Reduced
448
Closed
328

Sector Composition

1 Technology 30.99%
2 Consumer Discretionary 19.93%
3 Communication Services 10.14%
4 Financials 6.24%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NXTC icon
1426
NextCure
NXTC
$13M
-53
Closed -$4K
OCUL icon
1427
Ocular Therapeutix
OCUL
$2.37B
-1,750
Closed -$17K
OMER icon
1428
Omeros
OMER
$284M
-1,430
Closed -$19K
ORIC icon
1429
Oric Pharmaceuticals
ORIC
$1.06B
-900
Closed -$18K
OVID icon
1430
Ovid Therapeutics
OVID
$87.5M
-1,555
Closed -$5K
OVV icon
1431
Ovintiv
OVV
$10.6B
-22,572
Closed -$742K
PACB icon
1432
Pacific Biosciences
PACB
$381M
-4,560
Closed -$116K
PAG icon
1433
Penske Automotive Group
PAG
$12.4B
-14,527
Closed -$1.46M
PAHC icon
1434
Phibro Animal Health
PAHC
$1.6B
-465
Closed -$10K
PASG icon
1435
Passage Bio
PASG
$22.8M
-62
Closed -$12K
PBYI icon
1436
Puma Biotechnology
PBYI
$253M
-930
Closed -$6K
PCRX icon
1437
Pacira BioSciences
PCRX
$1.19B
-1,020
Closed -$57K
PCVX icon
1438
Vaxcyte
PCVX
$4.29B
-1,195
Closed -$30K
PGEN icon
1439
Precigen
PGEN
$1.3B
-4,725
Closed -$23K
PGNY icon
1440
Progyny
PGNY
$1.94B
-34,641
Closed -$1.94M
PLRX icon
1441
Pliant Therapeutics
PLRX
$114M
-820
Closed -$13K
PRTA icon
1442
Prothena Corp
PRTA
$460M
-1,030
Closed -$73K
PSNL icon
1443
Personalis
PSNL
$465M
-1,015
Closed -$19K
PTCT icon
1444
PTC Therapeutics
PTCT
$4.55B
-1,615
Closed -$60K
PTGX icon
1445
Protagonist Therapeutics
PTGX
$3.77B
-1,090
Closed -$19K
PULS icon
1446
PGIM Ultra Short Bond ETF
PULS
$12.3B
-4,714
Closed -$234K
QNCX icon
1447
Quince Therapeutics
QNCX
$86.5M
-680
Closed -$62K
QURE icon
1448
uniQure
QURE
$985M
-1,050
Closed -$33K
RAPT icon
1449
RAPT Therapeutics
RAPT
$214M
-84
Closed -$20K
RCKT icon
1450
Rocket Pharmaceuticals
RCKT
$354M
-1,455
Closed -$43K